Bio-Techne stock rebounds 2.17% as Bio-Techne announces integrated antibody workflow with Refeyn

Traders Union
All News
Companies
Bio-Techne gains 2.17% today

Highlights

TECH shares rebound 2.17% intraday, positioning above key support but below major moving averages, signaling near-term strength amid broader bearish pressure.
Momentum indicators flash mixed signals, with oscillators indicating an overbought market while trend measures highlight ongoing weakness and indecision.
Expected price range for the coming week is $48.00 to $52.00, with a breakout above $52.18 needed to reverse the prevailing downside risk.

Short-term gains as price holds above Ichimoku and near-term support

TECH (Bio-Techne) is trading at $50.85, currently above its 20-day SMA ($47.83), but below the 50-day ($52.18) and 200-day ($57.52) SMAs. This setup signals near-term bullish momentum, but medium- and long-term trends remain under seller pressure. The Ichimoku Kijun is at $50.11, which sits below the current price and now acts as immediate support. Near-term support is found at $50.11 (Kijun), with key support at $49.23 (MA-10). Resistance sits first at $52.18 (MA-50) and higher at $56.40 (MA-100).

Oscillator divergence as price rebounds within upper weekly range

Momentum signals are mixed. MACD on D1 indicates strong selling pressure, while ADX reads 22.71, reflecting a weak and indecisive trend. RSI on D1 is neutral-bullish at 52.47 and CCI is also positive, yet Stoch RSI and BBP signal an overbought, buyer-dominated market. Divergence persists as some oscillators flash overbought while others show underlying bullishness despite the negative MACD. Over the past week, TECH has slipped $0.83 (1.61%) from a previous close of $51.68. The price is now positioned in the upper part of the weekly range, with volatility standing at 8.58%. This reflects a steady decline from last week’s high, but a partial recovery from the weekly low. In today's session, the stock is up 2.17%, suggesting a rebound attempt following the earlier pullback.

Downside bias as sell signals outweigh limited bullish catalysts

Looking ahead, the expected price range for the coming week is $48.00 to $52.00, anchored close to the current price and reflecting both typical volatility and current momentum. This range remains well above the 52-week low of $43.20, but clearly below the 52-week high of $72.16. Probability of a price increase is very low (less than 20%) based on persistent sell signals from MA-50, RSI, MACD, and ADX on W1, making further downside more likely. The baseline scenario sees TECH consolidating between recent support and resistance as buying momentum battles longer-term selling pressure. A bullish scenario would require a confident breakout above $52.18, targeting the higher end of the range. If the price drops below $50.11, bearish momentum could accelerate toward $48.00 or lower support levels.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Bio-Techne was experiencing sustained downside pressure amid oversold technical conditions. In light of recent developments, investors should closely monitor for any shift in sentiment or potential confirmation of trend reversal, as the prevailing scenario continues to favor caution.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.